AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34374027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 32712654 — intervention group
Group type: EXPERIMENTAL
Intervention: Spot-stent grafting (SSG)
Number of subjects: 22
Study 36403953 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbed sutures
Number of subjects: 120
Study 36403953 — intervention group
Group type: EXPERIMENTAL
Intervention: VICRYL
Number of subjects: 120
Study 36403953 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethibond
Number of subjects: 120
Study 36403953 — intervention group
Group type: COMPARATOR
Intervention: Barbed sutures, VICRYL, Ethibond
Number of subjects: 120
Study 33054769 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes patients
Number of subjects: 474268
Study 33054769 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-, sex-, and diagnosis date-matched)
Number of subjects: 474268
Study 33054769 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes patients aged < 45 years
Number of subjects: 474268
Study 33054769 — intervention group
Group type: EXPERIMENTAL
Intervention: Some anti-diabetic medications
Number of subjects: 474268
Study 34062178 — intervention group
Group type: EXPERIMENTAL
Intervention: Story tweets
Number of subjects: 54
Study 34062178 — intervention group
Group type: COMPARATOR
Intervention: Standard tweets
Number of subjects: 54
Study 32460736 — intervention group
Group type: EXPERIMENTAL
Intervention: Home delivery assisted by non-skilled birth attendants
Number of subjects: 451
Study 32460736 — intervention group
Group type: EXPERIMENTAL
Intervention: Husband chooses the place of delivery
Number of subjects: 451
Study 32460736 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers' occupation
Number of subjects: 451
Study 32460736 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal care (ANC) visit
Number of subjects: 451
Study 32460736 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision making regarding delivery
Number of subjects: 451
Study 32460736 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of traditional remedies
Number of subjects: 451
Study 36752455 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid ablation (HA)
Number of subjects: 41
Study 32496397 — intervention group
Group type: EXPERIMENTAL
Intervention: Early inflammatory measures (cytokines, chemokines, growth factors)
Number of subjects: 62
Study 35044810 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 443
Study 35044810 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 443
Study 35044810 — intervention group
Group type: COMPARATOR
Intervention: Weekly paclitaxel (wP) followed by doxorubicin and cyclophosphamide
Number of subjects: 443
Study 35044810 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathologic complete response (pCR)
Number of subjects: 443
Study 35044810 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune activation markers
Number of subjects: 443
Study 33998026 — intervention group
Group type: EXPERIMENTAL
Intervention: Concern about the severity of HPAI
Number of subjects: 600
Study 33998026 — intervention group
Group type: EXPERIMENTAL
Intervention: Media and/or peer influence
Number of subjects: 600
Study 33998026 — intervention group
Group type: EXPERIMENTAL
Intervention: High importance of practicing water-related biosecurity
Number of subjects: 600
Study 33998026 — intervention group
Group type: EXPERIMENTAL
Intervention: Past experiences with HPAI
Number of subjects: 600
Study 33952200 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific age recall BMI trajectories
Number of subjects: 249
Study 33952200 — intervention group
Group type: EXPERIMENTAL
Intervention: Decade recall BMI trajectories
Number of subjects: 249
Study 33952200 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined models of specific age and decade recall BMI
Number of subjects: 249
Study 33198652 — intervention group
Group type: EXPERIMENTAL
Intervention: nab‐PTX plus RAM
Number of subjects: 251
Study 33198652 — intervention group
Group type: COMPARATOR
Intervention: PTX plus RAM
Number of subjects: 251
Study 33136223 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 1982
Study 33136223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1982
Study 33136223 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline walk distance ≤ 200 m
Number of subjects: 1982
Study 33136223 — intervention group
Group type: EXPERIMENTAL
Intervention: Decline in walk distance over 6 months
Number of subjects: 1982
Study 33977797 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (group A)
Number of subjects: 70
Study 33977797 — intervention group
Group type: COMPARATOR
Intervention: Control (group C)
Number of subjects: 70
Study 33495262 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions for the prevention of musculoskeletal pain and common mental disorders
Number of subjects: 0
Study 36050704 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac injection
Number of subjects: 64
Study 36050704 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone injection
Number of subjects: 64
Study 32694619 — intervention group
Group type: EXPERIMENTAL
Intervention: sHDCT/ASCT (salvage high-dose chemotherapy and autologous stem cell transplantation) with lenalidomide maintenance (10 mg/day) after 3 Rd reinduction cycles (lenalidomide 25 mg, day 1–21; dexamethasone 40 mg, day 1, 8, 15, and 22; 4-week cycles)
Number of subjects: 277
Study 32694619 — intervention group
Group type: COMPARATOR
Intervention: Continuous Rd (lenalidomide and dexamethasone)
Number of subjects: 277
Study 32694619 — intervention group
Group type: EXPERIMENTAL
Intervention: sHDCT/ASCT
Number of subjects: 277
Study 32694619 — intervention group
Group type: COMPARATOR
Intervention: Continuous Rd
Number of subjects: 277
Study 35627863 — intervention group
Group type: EXPERIMENTAL
Intervention: Fair condition (cooperation) in the prisoner’s dilemma game
Number of subjects: 342
Study 35627863 — intervention group
Group type: COMPARATOR
Intervention: Unfair condition (defection) in the prisoner’s dilemma game
Number of subjects: 342
Study 34280509 — intervention group
Group type: EXPERIMENTAL
Intervention: Circuit resistance training (1–3 rounds, 11 exercises, 10–15 reps, 50%–60% of 1RM, 3 times per week for 12 weeks)
Number of subjects: 34
Study 34280509 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study 35590451 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic job aid-supported nutrition counselling and practical demonstration
Number of subjects: 0
Study 35590451 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (comparison arm)
Number of subjects: 0
Study 34656026 — intervention group
Group type: EXPERIMENTAL
Intervention: NutriAct intervention group with supplementation of rapeseed oil and specifically designed foods, along with repetitive advice to implement a high-protein and high-polyunsaturated fatty acid dietary pattern.
Number of subjects: 502
Study 34656026 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group including dietary recommendations of the German Nutrition Society (DGE).
Number of subjects: 502
Study 32985089 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nursing based on wechat platform
Number of subjects: 95
Study 32985089 — intervention group
Group type: COMPARATOR
Intervention: Routine continuous nursing
Number of subjects: 95
Study 32750373 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program plus usual care
Number of subjects: 210
Study 32750373 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 210
Study 32571567 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninterrupted (or minimally interrupted) direct oral anticoagulants (DOACs)
Number of subjects: 0
Study 32571567 — intervention group
Group type: COMPARATOR
Intervention: Continuous vitamin K antagonists
Number of subjects: 0
Study 32482433 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise (TE) program in combination with the integrated neuromuscular inhibition technique (INIT)
Number of subjects: 40
Study 32482433 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic exercise (TE) program without the integrated neuromuscular inhibition technique (INIT)
Number of subjects: 40
Study 35648736 — intervention group
Group type: EXPERIMENTAL
Intervention: Answer boxes at the top of search results
Number of subjects: 1736
Study 35648736 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocal replies from an intelligent personal assistant (IPA)
Number of subjects: 1736
Study 35648736 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple questions posed to an IPA with biased answers
Number of subjects: 1736
Study 35648736 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple masking procedures
Number of subjects: 1736
Study 34126221 — intervention group
Group type: EXPERIMENTAL
Intervention: All-suture anchor (ASA) 2.6 mm
Number of subjects: 20
Study 34126221 — intervention group
Group type: COMPARATOR
Intervention: Metallic anchor (MA) 3.5 mm
Number of subjects: 20
Study 33168234 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized delayed-release and extended-release methylphenidate (DR/ER‐MPH)
Number of subjects: 0
Study 33517904 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls prevention exercise intervention (specific exercises not detailed)
Number of subjects: 23
Study 34198290 — intervention group
Group type: EXPERIMENTAL
Intervention: Fr16 access size
Number of subjects: 160
Study 34198290 — intervention group
Group type: EXPERIMENTAL
Intervention: Fr18 access size
Number of subjects: 160
Study 34198290 — intervention group
Group type: EXPERIMENTAL
Intervention: Fr20 access size
Number of subjects: 160
Study 34198290 — intervention group
Group type: EXPERIMENTAL
Intervention: Fr22 access size
Number of subjects: 160
Study 35013131 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (50 mg)
Number of subjects: 22
Study 32731836 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented tantalum metal tibial component
Number of subjects: 90
Study 32731836 — intervention group
Group type: COMPARATOR
Intervention: Cemented tibial component
Number of subjects: 90
Study 32731836 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented tibial component
Number of subjects: 90
Study 35058090 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative injection of 10 ml (133 mg) liposomal bupivacaine
Number of subjects: 0
Study 35058090 — intervention group
Group type: COMPARATOR
Intervention: Control group (no local anesthetic)
Number of subjects: 0
Study 33544448 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumpkin seed oil (PSO)
Number of subjects: 60
Study 33544448 — intervention group
Group type: COMPARATOR
Intervention: Minoxidil 5% foam
Number of subjects: 60
Study 33267706 — intervention group
Group type: EXPERIMENTAL
Intervention: Base-layer scrubs made of a cooling fabric
Number of subjects: 10
Study 33267706 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical scrubs
Number of subjects: 10
Study 32681303 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic and resistance exercise intervention (supervised, moderate-vigorous, thrice weekly for 16 weeks)
Number of subjects: 100
Study 32681303 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 32703288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)‐based depression prevention
Number of subjects: 130
Study 32703288 — intervention group
Group type: COMPARATOR
Intervention: Psycho-education (Control)
Number of subjects: 130
Study 36432607 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg·kg bw−1 of caffeine (CF8)
Number of subjects: 21
Study 34536801 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoclave aging
Number of subjects: 126
Study 34536801 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrothermal reactor aging
Number of subjects: 126
Study 34536801 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 126
Study 34983750 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated neonatal care kit (iNCK)
Number of subjects: 0
Study 34983750 — intervention group
Group type: COMPARATOR
Intervention: Current local standard of care
Number of subjects: 0
Study 33497547 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone-bupropion
Number of subjects: 403
Study 33497547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study 35460400 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen valerate pretreatment (2 mg twice a day from Day 7 after ovulation to Day 2 of the next menstrual cycle)
Number of subjects: 552
Study 35460400 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pretreatment)
Number of subjects: 552
Study 35460400 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen valerate pretreatment
Number of subjects: 552
Study 35460400 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 552
Study 34663095 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent partner treatment with oral metronidazole (400 mg) and 2% clindamycin cream applied topically to penile skin, both twice daily for 7 days.
Number of subjects: 34
Study 34663095 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent partner treatment
Number of subjects: 34
Study 32250461 — intervention group
Group type: COMPARATOR
Intervention: Current use of antidepressants (overall)
Number of subjects: 24155
Study 32250461 — intervention group
Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 24155
Study 32250461 — intervention group
Group type: COMPARATOR
Intervention: Trazodone
Number of subjects: 24155
Study 32250461 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 24155
Study 32250461 — intervention group
Group type: COMPARATOR
Intervention: Other antidepressants
Number of subjects: 24155
Study 34969175 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8399
Study 34969175 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399
Study 34482211 — intervention group
Group type: EXPERIMENTAL
Intervention: Active second stage of labour > 60 min
Number of subjects: 6804
Study 34482211 — intervention group
Group type: COMPARATOR
Intervention: Active second stage of labour ≤ 60 min
Number of subjects: 6804
Study 32960155 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT-WB (whole-body interval training)
Number of subjects: 41
Study 32960155 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT-T (treadmill-based interval training)
Number of subjects: 41
Study 32960155 — intervention group
Group type: EXPERIMENTAL
Intervention: MICT (moderate-intensity continuous training)
Number of subjects: 41
Study 33506929 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (L. rhamnosus GG) administered postoperatively for 30 days
Number of subjects: 40
Study 33506929 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition
Number of subjects: 40
Study 35487078 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS over left frontal pole (LFP)
Number of subjects: 24
Study 35487078 — intervention group
Group type: COMPARATOR
Intervention: Motor cortex rTMS
Number of subjects: 24
Study 33891478 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (5 weekly cycles of carboplatin and paclitaxel with concurrent radiotherapy at 41.4 Gy in 23 fractions, 5 days per week) followed by surgery
Number of subjects: 366
Study 33891478 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy
Number of subjects: 366
Study 33891478 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 366
Study 33089619 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermocoagulation
Number of subjects: 149
Study 33089619 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 149
Study 35142560 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise bout before vaccination
Number of subjects: 60
Study 35142560 — intervention group
Group type: COMPARATOR
Intervention: Control group (rest before vaccination)
Number of subjects: 60
Study 34545701 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 1138
Study 34545701 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1138
Study 36011679 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcurrent therapy
Number of subjects: 30
Study 36011679 — intervention group
Group type: COMPARATOR
Intervention: Sham microcurrent stimulation
Number of subjects: 30
Study 32936533 — intervention group
Group type: EXPERIMENTAL
Intervention: Test metformin hydrochloride tablet (0.25 g)
Number of subjects: 56
Study 32936533 — intervention group
Group type: COMPARATOR
Intervention: Reference metformin hydrochloride tablet (0.25 g)
Number of subjects: 56
Study 32936533 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat and high-calorie diet
Number of subjects: 56
Study 36440744 — intervention group
Group type: EXPERIMENTAL
Intervention: Action observation therapy
Number of subjects: 12
Study 36440744 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy and action observation
Number of subjects: 12
Study 32331505 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational software
Number of subjects: 153
Study 32331505 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational booklet
Number of subjects: 153
Study 32331505 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 153
Study 32046899 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-NFB protocol aimed at increasing the low-Î²(SMR)/high-Î² ratio, n = 16
Number of subjects: 32
Study 32046899 — intervention group
Group type: COMPARATOR
Intervention: EEG-NFB protocol aimed at increasing the Î±(Î¼)/Î¸ ratio, n = 16
Number of subjects: 32
Study 35334953 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet for eight weeks
Number of subjects: 19
Study 35334953 — intervention group
Group type: COMPARATOR
Intervention: Placebo during double-blinded provocations
Number of subjects: 19
Study 32294394 — intervention group
Group type: EXPERIMENTAL
Intervention: Greek yogurt with granola (150 kcal, 9.2 g protein, 2.6 g fat, 2.0 g dietary fibre, and 21.5 g available carbohydrate/100 g)
Number of subjects: 24
Study 32294394 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultured coconut product with granola (146 kcal, 3.2 g protein, 3.2 g fat, 5.6 g dietary fibre, and 21.9 g available carbohydrate/100 g)
Number of subjects: 24
Study 32294394 — intervention group
Group type: COMPARATOR
Intervention: Water control
Number of subjects: 24
Study 33593220 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous microwave ablation (MWA)
Number of subjects: 496
Study 33593220 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram and ANN model
Number of subjects: 496
Study 33221899 — intervention group
Group type: EXPERIMENTAL
Intervention: CEDs with warning labels
Number of subjects: 2040
Study 33221899 — intervention group
Group type: EXPERIMENTAL
Intervention: Warnings on the back of CED cans featuring large font, a border, and a 'caution' heading
Number of subjects: 2040
Study 33221899 — intervention group
Group type: EXPERIMENTAL
Intervention: Front‐of‐package 'High source of caffeine' labels
Number of subjects: 2040
Study 33221899 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative caffeine statement
Number of subjects: 2040
Study 33221899 — intervention group
Group type: EXPERIMENTAL
Intervention: Existing warning statements in Canada
Number of subjects: 2040
Study 33892599 — intervention group
Group type: EXPERIMENTAL
Intervention: FACT intervention
Number of subjects: 57
Study 33892599 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study 33814283 — intervention group
Group type: EXPERIMENTAL
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 80% COZD
Number of subjects: 32
Study 33814283 — intervention group
Group type: EXPERIMENTAL
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 90% COZD
Number of subjects: 32
Study 33814283 — intervention group
Group type: EXPERIMENTAL
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 90-100% COZD
Number of subjects: 32
Study 33814283 — intervention group
Group type: COMPARATOR
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 60% COZD
Number of subjects: 32
Study 33814283 — intervention group
Group type: COMPARATOR
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 70% COZD
Number of subjects: 32
Study 33814283 — intervention group
Group type: COMPARATOR
Intervention: Centre-distance simultaneous-image multifocal contact lenses (SIMCLs) with 60% and 70% COZDs
Number of subjects: 32
Study 33242444 — intervention group
Group type: EXPERIMENTAL
Intervention: D-VTd
Number of subjects: 1085
Study 33242444 — intervention group
Group type: COMPARATOR
Intervention: VTd
Number of subjects: 1085
Study 35262874 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV Biofeedback (HRV-BF)
Number of subjects: 84
Study 35262874 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 84
Study 34059090 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS + VCT
Number of subjects: 23
Study 32845825 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecological-belonging intervention
Number of subjects: 1822
Study 32845825 — intervention group
Group type: COMPARATOR
Intervention: Business-as-usual controls
Number of subjects: 1822
Study 36011491 — intervention group
Group type: EXPERIMENTAL
Intervention: My Jump 2 app in standing position
Number of subjects: 39
Study 36011491 — intervention group
Group type: EXPERIMENTAL
Intervention: My Jump 2 app in standardized position
Number of subjects: 39
Study 36011491 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean observations in each height
Number of subjects: 39
Study 35257001 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided, online single-session mental health interventions (SSIs) in a randomized controlled trial (RCT) where participants were paid for participation
Number of subjects: 2436
Study 35257001 — intervention group
Group type: COMPARATOR
Intervention: Self-guided, online single-session mental health interventions (SSIs) in a program evaluation project where participants were not paid for participation
Number of subjects: 2436
Study 35870236 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal group paradigm
Number of subjects: 192
Study 35870236 — intervention group
Group type: COMPARATOR
Intervention: Minimal group
Number of subjects: 192